MSAA Chooses SEQSTER for Patient-Centric Innovation

SEQSTER PDM Inc. (SEQSTER), a leading patient-centric healthcare technology company, has been chosen by the Multiple Sclerosis Association of America (MSAA) for its patient-centricity, 1-Click Records™, and advanced longitudinal health record. SEQSTER brings together individuals living with multiple sclerosis (MS), researchers, and care centers across the nation.

This selection comes after MSAA launched the Multiple Sclerosis Implementation Network™ (MSIN™) in partnership with Novartis Pharmaceuticals Corporation in May 2023. MSIN is a patient-centered initiative aimed at enhancing care quality and health outcomes for individuals with MS. Through connecting healthcare professionals, sharing data and insights, and developing a research-focused data environment, MSIN powered by SEQSTER’s innovative operating system aims to be a model of innovation and evidence-based care.

The collaboration with SEQSTER’s Operating System allows participating healthcare professionals to share experiences, learn from one another, and contribute to research for improving care quality and health outcomes in MS. Ardy Arianpour, CEO & Co-Founder of SEQSTER, expresses enthusiasm for this transformative initiative and the potential it holds to revolutionize MS treatment and management.

Gina Ross Murdoch, President and CEO of MSAA, emphasizes the importance of this research collaboration in identifying optimal MS treatment and management strategies. The MSIN initiative, driven by SEQSTER’s advanced operating system, integrates clinical insights with perspectives from individuals living with MS and their caregivers, aligning with MSAA’s mission of Improving Lives Today for the entire MS community.

Dr. Maria E. Fernandez, PhD, and Dr. Leorah Freeman, MD, PhD, will lead MSIN as Principal Investigators, bringing expertise in population health, implementation science, and MS care and research to drive impactful outcomes for individuals with MS.

Source link

Newsletter Updates

Enter your email address below and subscribe to our newsletter